Michelle Rubin-Onur, PhD

Director of Regulatory

Michelle has prior experience as both an in-house regulatory leader and a regulatory consultant. As the Director of Regulatory and Quality at Blue Note Therapeutics, a digital therapeutics company, Michelle owned, developed, and implemented the regulatory strategies for all of the company’s mobile applications, including multiple artificial intelligence/machine learning (AI/ML) products. 

Prior to Blue Note Therapeutics, Michelle worked as a regulatory consultant, authoring and leading numerous premarket submissions and regulatory strategies for Class I-III devices, including radiation therapy systems, implantable markers, surgical instruments, nerve stimulators, in-vitro diagnostics, and powered wheelchairs. Michelle holds a PhD in Biomedical Sciences from Baylor College of Medicine and is passionate about ensuring that patients have access to the clinically proven treatments they need.

Wondering which QMS is right for you?
This is default text for notification bar